18 May 2021
What is a healing-targeted drug-eluting stent and how is it different to a normal stent?
Sponsored by Sinomed B.V.
Speakers:
A. Baumbach, P. Serruys
Summary
Watch this session presented by Andreas Baumbach and Patrick W. Serruys in order to understand what is a healing-targeted (HT) drug-eluting stent (DES) and what are the potential benefits, to review recent clinical data of the HT DES from the PIONEER III trial, and to learn about future clinical trials that may take advantage of the HT concept.
Learning Objectives
- To understand what is a healing-targeted (HT) drug-eluting stent (DES) and what are the potential benefits
- To review recent clinical data of the HT DES from the PIONEER III trial
- To learn about future clinical trials that may take advantage of the HT concept